Dual-Target CAR-NK Cells for Biomarker-Selected Advanced Colorectal Cancer

Clinical trial NCT07462650 · RECRUITING

Trial details

NCT number: NCT07462650
Sponsor: Beijing Biotech
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Metastatic Adenocarcinoma of Colon

Start date: 2026-02-01
Primary completion: 2027-12-21
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.